humira and semaglutide for HS (Hidradenitis Suppurativa) GLP-1 for Crohn's Disease: Current

This article examines the evidence, UK guidance, and practical strategies for managing diabetic retinopathy risk in patients receiving semaglutide therapy

Our dedicated care team simplifies semaglutide insurance coverage, verifying patient benefits and managing the prior authorization process

An Evolutionary Perspective on the Obesity Epidemic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012

The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply

Stobaus N, Pirlich M, Valentini L, Schulzke JD, Norman K